.svg)
You are now leaving Astellas.us. The website you are linking to is neither owned nor controlled by Astellas.
Astellas is not responsible for the content or services on this site.
News Releases
Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.
-
Aug 3, 2018
Jul 23, 2018Dr. Halit Bander named VP, Oncology, Medical Affairs; Moyra Knight named VP, Corporate Communications; Maribeth Landwehr named Executive Director, Corporate Communications-
Jul 13, 2018First and Only Oral Treatment FDA-Approved for Both Non-Metastatic and Metastatic CRPC
-
Jul 9, 2018-Enrollment of EV-201 Pivotal Trial Cohort Designed to Support Potential Expedited Registration Pathway in the U.S. Completed-
Jun 19, 2018Employees Also Raised More Than $55,000 at Third Annual "One Astellas Spirit Run" for Seven Charitable Organizations
-
Jun 3, 2018-Updated Data from Phase 1 EV-101 Study Highlighted in ASCO 2018 Oral Presentation Support Rapid Development Program and Ongoing Pivotal Study-
-
May 31, 20182018 Challenge Will Award a Total of $100,000 in New Grants to Help Reduce the Unequal Burden of Cancer